Newly released documents reveal Epstein’s ongoing influence with Trump, top officials and major media figures long after his ...

HCW11-040 is a first-in-class pembrolizumab-based, tetra-valent immune checkpoint inhibitor designated as Company’s franchise ...

HCW Biologics debuted the results from its preclinical study of HCW11-018b, the Company’s lead T-cell engager product candidate, that highlights the uniqueness and advantages of its second-generation ...

New diagnostic kits aim to revolutionize early screening of the disease, potentially allowing patients to receive ...

Q3 2025 Management View CEO Dietrich Pauls highlighted ongoing progress for DM199, the lead product candidate, emphasizing ...

Eilean Therapeutics LLC is a biopharmaceutical company focused on the discovery and development of best-in-class and first-in-class small-molecule therapies addressing genetic and signaling ...

Yesterday at the Ernest N Morial Convention Center, latest clinical trial findings were disclosed on the use of human engineered heart muscle as biological ventricular assist tissue (BioVAT) ...

Research on adults who take S.S.R.I.s shows they tamp down sexual desire. Why aren’t we studying what that could mean for ...

Raffles Health Insurance is the only insurer that has not raised premiums for two consecutive years. Read more at ...

Novel INDUCER™ T Cell Engager Platform designed to mitigate systemic toxicitiesSequential dosing of INDUKINE™ molecules in preclinical model ...

Two presentations, including one oral session, build on existing data and show deep and durable clinical remission rates, combined with a strong safety profile, for SENTI-202 in treating ...

The FDA has issued a safety alert regarding serious injuries from radiofrequency (RF) microneedling. Reported complications ...